These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3475924)

  • 1. Thyrocytes can synthesize HLA class II molecules.
    Londei M; Grubeck-Loebenstein B; Kissonerghis M; Austin P; Trowsdale J; Greenall C; Feldmann M
    Acta Endocrinol Suppl (Copenh); 1987; 281():82-5. PubMed ID: 3475924
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulatory activities of antigen presenting cells in mixed leucocyte reactions (MLR) in thyroid diseases.
    Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Waldhäusl W; Feldmann F
    Acta Endocrinol Suppl (Copenh); 1987; 281():89-92. PubMed ID: 2956819
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
    Kissonerghis AM; Grubeck-Loebenstein B; Pirich K; Feldmann M; Londei M
    Autoimmunity; 1989; 4(4):255-66. PubMed ID: 2518829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
    Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
    J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
    J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of class-II antigen expression in human thyroid epithelial cell cultures.
    Wenzel BE; Arnholdt H; Grammerstorf S; Gutekunst R; Scriba PC
    Acta Endocrinol Suppl (Copenh); 1987; 281():21-6. PubMed ID: 3475903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
    Bodolay E; Szegedi G; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
    Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules.
    Catálfamo M; Serradell L; Roura-Mir C; Kolkowski E; Sospedra M; Vives-Pi M; Vargas-Nieto F; Pujol-Borrell R; Jaraquemada D
    Int Immunol; 1999 Feb; 11(2):269-77. PubMed ID: 10069425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.
    Todd I; Pujol-Borrell R; Hammond LJ; McNally JM; Feldmann M; Bottazzo GF
    Clin Exp Immunol; 1987 Sep; 69(3):524-31. PubMed ID: 2822302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyrocyte HLA class II expression and regulation in relation to thyroid autoimmunity.
    Todd I; Pujol-Borrell R; Belfiore A; Bottazzo GF
    Acta Endocrinol Suppl (Copenh); 1987; 281():27-34. PubMed ID: 3497511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R
    J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of rat thyroid cell MHC class II antigen by thyrotropin and gamma-interferon.
    Platzer M; Neufeld DS; piccinini LA; Davies TF
    Endocrinology; 1987 Dec; 121(6):2087-92. PubMed ID: 3119313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.
    Todd I; Pujol-Borrell R; Abdul-Karim BA; Hammond LJ; Feldmann M; Bottazzo GF
    Clin Exp Immunol; 1987 Sep; 69(3):532-42. PubMed ID: 3117460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
    Aguayo J; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.
    Ciampolillo A; Napolitano G; Mirakian R; Miyasaki A; Giorgino R; Bottazzo GF
    Clin Exp Immunol; 1993 Dec; 94(3):478-85. PubMed ID: 7902787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor and transforming growth factor-alpha suppress HLA class II induction in human thyroid epithelial cells.
    Todd I; Hammond LJ; James RF; Feldmann M; Bottazzo GF
    Immunology; 1990 Jan; 69(1):91-6. PubMed ID: 2107145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DP, DQ and DR gene expression in Graves' disease and normal thyroid epithelium.
    Piccinini LA; Goldsmith NK; Roman SH; Davies TF
    Tissue Antigens; 1987 Oct; 30(4):145-54. PubMed ID: 3120348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction enzyme analysis of HLA class II DR beta genes in patients with Graves' disease.
    Boehm BO; Schifferdecker E; Kuehnl P; Rosak C; Schöffling K
    Acta Endocrinol Suppl (Copenh); 1987; 281():146-8. PubMed ID: 3039771
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA-DR gene expression in a proliferating human thyroid cell clone (12S).
    Cone RD; Platzer M; Piccinini LA; Jaramillo M; Davies TF
    Endocrinology; 1988 Oct; 123(4):2067-74. PubMed ID: 2843357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.